Text Module

Share

Program Content

Activities

  • Treatment of HER2-Negative EBC
    Expert Review of Treatment for HER2-Negative Early Breast Cancer
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 31, 2023

    Expires: August 30, 2024

Faculty

cover img faculity

Kevin Kalinsky, MD, MS

Division Director, Medical Oncology
Professor, Department of Hematology and Medical Oncology
Winship Cancer Institute at Emory University
Atlanta, Georgia

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca and Merck Sharp & Dohme LLC.

AstraZeneca

Merck Sharp & Dohme, LLC

Partners

Smart Patients

ProCE Banner